Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Lund University
Lund, SueciaPublicaciones en colaboración con investigadores/as de Lund University (30)
2024
-
Dealing With Temporality in Patients With Life-Limiting Disease: An International Qualitative Study
Qualitative Health Research
-
‘Someone must do it’: multiple views on family’s role in end-of-life care – an international qualitative study
Palliative Care and Social Practice, Vol. 18
2021
-
A lifestyle intervention with an energy-restricted Mediterranean diet and physical activity enhances HDL function: a substudy of the PREDIMED-Plus randomized controlled trial
The American journal of clinical nutrition, Vol. 114, Núm. 5, pp. 1666-1674
-
CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation
Nature Communications, Vol. 12, Núm. 1
-
Mediterranean, DASH, and MIND Dietary Patterns and Cognitive Function: The 2-Year Longitudinal Changes in an Older Spanish Cohort
Frontiers in Aging Neuroscience, Vol. 13
2020
-
Development of an international Core Outcome Set (COS) for best care for the dying person: study protocol
BMC Palliative Care, Vol. 19, Núm. 1
-
Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis
Scientific Reports, Vol. 10, Núm. 1
2019
-
Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)
Nature Immunology
-
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology, Vol. 30, Núm. 8, pp. 1194-1220
-
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia
Scientific Reports, Vol. 9, Núm. 1
-
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
Nature Medicine, Vol. 25, Núm. 1, pp. 152-164
-
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development
Nature Immunology
2018
-
Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Annals of Oncology, Vol. 29, Núm. 2, pp. 405-417
-
Complement C4d-specific antibodies for the diagnosis of lung cancer
Oncotarget, Vol. 9, Núm. 5, pp. 6346-6355
-
How do experienced professors teach palliative medicine in european universities? a cross-case analysis of eight undergraduate educational programs
Journal of Palliative Medicine, Vol. 21, Núm. 11, pp. 1621-1626
-
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies
PLoS Medicine, Vol. 15, Núm. 1
2017
-
Balancing Upstream and Downstream Measures to Tackle the Obesity Epidemic: A Position Statement from the European Association for the Study of Obesity
Obesity Facts, Vol. 10, Núm. 1, pp. 61-63
-
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study
Leukemia, Vol. 31, Núm. 11, pp. 2443-2448
-
Second primary malignancies in multiple myeloma: An overview and IMWG consensus
Annals of Oncology, Vol. 28, Núm. 2, pp. 228-245
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97